Affiliations: Centro CNR per la Medicina Nucleare, Istituto di Scienze Radiologiche, Fondazione Pascale and Universita D., Napoli, Italy
CNR Medicina Nucleare, Universita degli Studi di Napoli F., Via Pansini 5-80131, Napoli, Italy
References: Aaronen, H.J., Gazit, I.E., Louis, D.N., Cerebral blood volume maps of gliomas: Comparison with tumor grade and histologic findings (1994) Radiology, 191, pp. 41-5
Abe, Y., Fukuda, H., Ishiwata, K., Studies on 18F-labeled pyrimidines: Tumor uptake of 18F-5-fluorouracil, 18F-5-fluorouridine, 18F-5-fluorodeoxyuridine (1983) Eur. J. Nucl. Med., 8, pp. 258-261
Al Aish, M., Coleman, R.F., Larson, S.M., Advances in clinical imaging using positron emission tomography. National Cancer Institute workshop statement (1990) Arch. Intern. Med., 150, pp. 735-739
Alger, J.R., Frank, J.A., Bizzi, A., Metabolism of human gliomas: Assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET (1990) Radiology, 177, pp. 633-641
Alger, J.R., Symko, S.C., Bizzi, A., Absolute quantitation of short TE brain 1H-MR spectra and spectroscopic imaging data (1993) J. Comput. Assist. Tomogr., 17, pp. 191-199
Alavi, J.B., Alavi, A., Chawluk, J., Positron emission tomography in patients with glioma - A predictor of prognosis (1988) Cancer, 62, pp. 1074-1078
Ancri, D., Basset, J.Y., Lonchampt, M.F., Etavard, C., Diagnosis of cerebral lesions by thallium-201 (1978) Radiology, 128, pp. 417-422
Andersson, J.L.R., Sundin, A., Valind, S., A method for coregistration of PET and MR brain images (1995) J. Nucl. Med., 36, pp. 1307-1315
Ando, A., Ando, I., Katayama, J., Biodistribution of radioactive alkaline metals in tumor bearing animals: Comparison with Tl-201 (1988) Eur. J. Nucl. Med., 14, pp. 352-357
Babich, J.W., Keeling, F., Flower, M.A., Initial experience with Tc-99m-HMPAO in the study of brain tumors (1988) Eur. J. Nucl. Med., 14, pp. 34-44
Baillet, G., Albuquerque, L., Chen, Evaluation of single-photon emission tomography imaging of supratentorial brain gliomas with technetium-99m sestamibi (1994) Eur. J. Nucl. Med., 21, pp. 1061-1066
Behars, O.H., Henson, D.E., Hutter, R.V.P., Myers, M.H., (1988) Manual for Staging Cancer (AJCC), , Lippincott, Philadelphia
Behl, C., Winkler, J., Bogdahn, U., Autocrine growth regulation in neuroectodermal tumors as detected with oligodeoxynucleotide antisense molecules (1993) Neurosurgery, 33, pp. 679-684
Beller, G., Watson, D.D., Physiological basis of myocardial perfusion imaging with the Tc-99m agents (1991) Semin. Nucl. Med., 21, pp. 173-181
Bentson, J.R., Steckel, R.J., Kagan, A.R., Diagnostic imaging in clinical cancer management: Brain metastases (1988) Invest. Radiol., 23, pp. 335-341
Bergström, M., Collins, V.P., Ehrin, E., Discrepancies in brain tumor extent as shown by CT and PET using (68Ga)EDTA, (11C)glucose and (11C)methionine (1983) J. Comput. Assist. Tomogr., 7, pp. 1062-1066
Bergström, M., Ericson, K., Hagenfeld, L., Studies of methionine accumulation in glioma and normal brain tissue: Competition with branched-chain amino acids (1987) J. Comput. Assist. Tomogr., 11, pp. 208-213
Bergström, M., Lundqvist, H., Ericson, A., Comparison of the accumulation kinetics of L-(methyl-11C)-methionine and D-(methyl-11C)-methionine in brain tumors studied with positron emission tomography (1987) Acta Radiol., 28, pp. 225-229
Bergström, M., Muhr, C., Lundberg, P.O., Rapid decrease in amino acid metabolism in prolactin secreting pituitary adenomas after bromocriptine treatment: A PET study (1987) J. Comput. Assist. Tomogr., 11, pp. 815-819
Biersack, H.J., Coenen, H.H., Stocklin, G., Imaging of brain tumors with L-3-(123I)iodo-α-methyl tyrosine and SPECT (1989) J. Nucl. Med., 30, pp. 110-112
Biersack, H.J., Grunwald, F., Kropp, J., Single photon emission computed tomography imaging of brain tumours (1991) Semin. Nucl. Med., 21, pp. 2-10
Birnbaum, M.J., Haspel, H.C., Rosen, O.M., Transformation of rat fibroblasts by FSV rapidly increases glucose transport gene transcription (1987) Science, 233, pp. 1495-1498
Black, K.L., Hawkins, R.A., Kim, K.T., Use of thallium-201 SPECT to quantitate malignancy grade of gliomas (1989) J. Neurosurg., 71, pp. 342-346
Blacklock, J.B., Oldfield, E.H., Di Chiro, G., Effect of barbiturate coma on glucose utilization in normal brain versus gliomas: Positron emission tomography studies (1987) J. Neurosurg., 67, pp. 71-75
Bogdahn, U., Froelich, T., Krone, A., Vascularization of primary central nervous system tumors: Detection with contrast-enhanced transcranial color-coded real-time sonography (1994) Radiology, 192, pp. 141-148
Bolster, J.M., Vaalburg, M., Paans, A.M.J., Carbon-11-labeled tyrosine to study tumor metabolism by positron emission tomography (PET) (1986) Eur. J. Nucl. Med, 12, pp. 321-324
Bottomley, P.A., The trouble with spectroscopy papers (1993) Radiology, 187, pp. 433-437
Bovee, W.M.M.J., Keevil, S.F., Leach, M.O., Podo, F., Quality assessment in in vivo NMR spectroscopy: A protocol for quality assessment (1995) Magn. Reson. Imaging, 13, pp. 123-129
Brismar, T., Collins, V.P., Kesselberg, M., Thallium-201 uptake relates to membrane potential and potassium permeability in human glioma cells (1989) Brain Res., 500, pp. 30-36
Brooks, D.J., Beancy, R.P., Lammerstma, A.A., Quantitative measurement of blood-brain barrier permeability using rubidium-82 and positron emission tomography (1984) J. Cereb. Blood Flow Metab., 4, pp. 535-545
Brooks, D.J., Beany, R.P., Thomas, D.G.T., Studies on regional cerebral pH in patients with cerebral tumors using continuous inhalation of 11CO2 and positron emission tomography (1986) J. Cereb. Blood Flow Metab., 6, pp. 529-535
Bruhn, H., Frahm, J., Gyngell, M.L., Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: Initial experience in patients with cerebral tumors (1989) Radiology, 172, pp. 541-548
Brunetti, A., Blasberg, R.G., Finn, R.D., Larson, S.M., Gallium transferrin as a macromolecular tracer of vascular permeability (1988) Int. J. Rad. Appl. Instrum. [B], 15, pp. 665-672
Buchpiguel, C.A., Alavi, J.B., Alavi, A., Kenyon, L.C., PET versus SPECT in distinguishing radiation necrosis from tumor recurrence in the brain (1991) J. Nucl. Med., 36, pp. 159-164
Burger, P.C., Shibata, T., Kleihues, P., The use of monoclonal antibody Ki-67 in the identification of proliferating cells: Applications to surgical neuropathology (1986) Am. J. Surg. Pathol., 10, pp. 611-617
Burger, P.C., Kleihues, P., Cytologic composition of the untreated glioblastoma with implications for evaluation of needle biopsy (1989) Cancer, 63, pp. 2014-2032
Burger, P.C., Scheithauer, B.W., Vogel, F.S., (1991) Surgical Pathology of the Nervous System and Its Coverings, 3rd Edn., , Churchill Livingstone, New York
Burkard, R., Kaiser, K.P., Wieler, H., Contribution of thallium-201-SPECT to the grading of tumorous alteration of the brain (1992) Neurosurg. Rev., 15, pp. 265-273
Bustany, P., Chatel, M., Delon, J.M., Brain tumor protein synthesis and histologic grades: A study by positron emission tomography (PET) with 11C-L-methionine (1986) J. Neurooncol., 3, pp. 397-402
Buxton, R.B., Wechsler, L.R., Alpert, N.M., Measurement of brain pH using 11CO and positron emission tomography (1984) J. Cereb. Blood Flow Metab., 4, pp. 8-16
Byrne, T.N., Imaging of gliomas (1994) Semin. Oncol., 21, pp. 162-171
Carvalho, P.A., Schwartz, R.B., Alexander E. III, Detection of recurrent gliomas with quantitative thallium-201/technetium-99m HMPAO single photon emission computerized tomography (1992) J. Neurosurg., 77, pp. 565-570
Cherry, S.R., Dahlbom, M., Huffman, E.J., Three-dimensional positron emission tomography using a conventional multi-slice tomograph without septa (1991) J. Comput. Assist. Tomogr., 15, pp. 655-668
Christiansen, P., Henriksen, O., Stubgaard, In vivo quantification of brain metabolites by 1H-MRS using water as an internal standard (1993) Magn. Reson. Imaging, 11, pp. 107-118
Coleman, R.E., Hoffman, J.J., Hanson, M.W., Sostman, H.D., Schold, S.C., Clinical applications of PET for evaluation of brain tumors (1991) J. Nucl. Med., 32, pp. 616-622
Coons, S.W., Johnson, P.C., Regional heterogeneity in the DNA content of human gliomas (1993) Cancer, 72, pp. 3052-3060
Connelly, A., Jackson, G.D., Frackowiack, R.S.J., High resolution functional mapping of activated human primary cortex using a clinical magnetic resonance imaging system (1993) Radiology, 188, pp. 125-130
Cox, P.H., Belfer, A.J., Van Der Pompe, W.B., Thallium-201 uptake in tumours: A possible complication on heart scintigraphy (1976) Br. J. Radiol., 49, pp. 767-768
Daemen, B.J.G., Zwertrbroek, R., Elsinga, P.H., PET studies of L-[I-11C]tyrosine, L-[methyl-11C]methionine and 18F-fluorodeoxyglucose in prolactinomas in relation to bromocriptine treatment (1991) Eur. J. Nucl. Med., 18, pp. 453-460
Dalla Palma, L., Magnaldi, S., Ricci, C., Longo, R., Spettroscopia clinica a risonanza magnetica (clinical magnetic resonance spectroscopy) (1992) Radiol. Med., 83, pp. 7-23
Damadian, R., Tumor detection by nuclear magnetic resonance (1971) Science, 171, pp. 1151-1153
Damadian, R., Zaner, K., Hor, D., Dimaio, T., Human tumors by NMR (1973) Physiol. Chem. Phys., 5, pp. 381-402
Dann, R., Hoford, J., Kovacic, S., Evaluation of elastic matching system for anatomic (CT, MR) and functional (PET) cerebral images (1989) J. Comput. Assist. Tomogr., 13, pp. 603-611
Daumas-Duport, C., Scheithauer, B.W., O'Fallon, J., Kelly, P., Grading of astrocytomas: A simple and reproducible method (1988) Cancer, 62, pp. 2152-2165
Davis, W.K., Boyko, O.B., Hoffman, J.M., [11F]2-Fluoro-2-deoxyglucose-positron emission tomography correlation of gadolinium-enhanced MR imaging of central nervous system neoplasia (1993) AJNR, 14, pp. 515-523
Dean, B.L., Drayer, B.P., Bird, C.R., Gliomas: Classification with MR imaging (1990) Radiology, 174, pp. 411-415
De Beer, R., Bachert-Baumann, P., Bovee, W.M.M.J., Quality assessment in in vivo NMR spectroscopy: Multicentre quantification of MRS test signals (1995) Magn. Reson. Imaging, 13, pp. 169-176
De La Paz, R.L., Patronas, N.J., Brooks, R.A., Positron emission tomographic study of suppression of gray matter glucose utilization by brain tumors (1983) AJNR, 4, pp. 826-829
Demaerel, P., Johannik, K., Van Ecke, P., Localized 1H-nmr spectroscopy in fifty cases of newly diagnosed intracranial tumors (1991) J. Comput. Assist. Tomogr., 15, pp. 67-76
De Michele, D.J., Di Chiro, G., Grading meningiomas by positron emission tomography (1991) Meningiomos, pp. 243-251. , (Edited by Al Mefty O.). Raven Press, New York
Den Hollander, J.A., Luyten, P.R., Mariaen, J.H., Potentials of quantitative image-localized 31P nuclear magnetic resonance spectroscopy in the clinical evaluation of intracranial tumors (1989) Magn. Reson. Q., 5, pp. 152-168
De Souza, B., Brunetti, A., Fulham, M.J., Pituitary micro-adenomas: A PET study (1990) Radiology, 177, pp. 39-44
Di Chiro, G., De La Paz, Brooks, R.A., Glucose utilization of cerebral gliomas measured by 18-fluorodeoxyglucose and PET (1982) Neurology, 32, pp. 1323-1329
Di Chiro, G., Positron emission tomography using [18F]-fluorodeoxyglucose in brain tumors - A powerful diagnostic and prognostic tool (1987) Invest. Radiol, 22, pp. 360-371
Di Chiro, G., Hatazawa, J., Katz, D.A., Rizzoli, H.V., DeMichele, D.J., Glucose utilization and intracranial meningiomas as an index of tumor aggressivity and probability of recurrence: A PET study (1987) Radiology, 164, pp. 521-526
Di Chiro, G., Brooks, R.A., PET quantitation: Blessing and curse (1988) J. Nucl. Med., 29, pp. 1603-1604
Di Chiro, G., Fulham, M.J., Virchow's shackles: Can PET-FDG challenge tumor histology? (1993) AJNR, 14, pp. 524-527
Dierckx, R.A., Martin, J.J., Dobbleir, A., Crois, R., Neetens, I., De Deyn, P.P., Sensitivity and specificity of thallium-201 single photon emission tomography in the functional detection and differential diagnosis of brain tumors (1994) Eur. J. Nucl. Med., 21, pp. 621-633
Doyle, W.K., Budinger, T.F., Valk, P.E., Differentiation of cerebral radiation necrosis from tumor recurrence by [18F]FDG and 82Rb positron emission tomography (1987) J. Comput. Assist. Tomogr., 11, pp. 563-570
Drane, W.E., Abbott, F.D., Nicole, M.W., Technology for FDG-SPECT with a relatively inexpensive gamma camera: Work in progress (1994) Radiology, 191, pp. 461-465
El Gazzar, A.H., Fernandez-Ullo, M., Silberstein, E.B., Tl-201 as a tumor-localizing agent: Current status and future considerations (1993) Nucl. Med. Commun., 14, pp. 96-103
Ell, P.J., Jarritt, H., Costa, D.C., Functional imaging of the brain (1987) Semin. Nucl. Med., 17, pp. 214-229
Endicott, J.A., Ling, V., The biochemistry of P-glycoprotein-mediated drug resistance (1989) Annu. Rev. Biochem., 58, pp. 137-171
Ericson, K., Lilja, A., Bergstrom, M., Positron emission tomography with (methyl-11-C)-L-methionine, 11-C-glucose and 68-Ga EDTA in the examination of supratentorial tumors (1985) J. Comput. Assist. Tomogr., 9, pp. 683-689
Ernst, R.R., Anderson, W.A., Application of fourier transform spectroscopy to magnetic resonance (1966) Rev. Sci. Instrum., 37, pp. 93-102
Evans, A.C., Beil, C., Marrett, S., Anatomical-functional correlation using an adjustable MRI-based region of interest atlas with positron emission tomography (1988) J. Cereb. Blood Flow Metab., 8, pp. 515-530
Farde, L., Ehrin, E., Eriksson, L.E., (1985) Substituted Benzamides As Ligand for Visualization of Dopamine Receptor Binding in the Human Brain by Positron Emission Tomography, 82, pp. 3863-3867
Fowler, J.S., Hoffman, E.J., Larson, S.M., Positron emission tomography in oncology (1988) JAMA, 259, pp. 2126-2131
Frahm, J., Bruhn, H., Hanicke, W., Localized proton NMR spectroscopy of brain tumors using short echo time STEAM sequences (1991) J. Comput. Assist. Tomogr., 15, pp. 915-922
Francavilla, T.L., Miletich, R.S., Di Chiro, G., Positron emission tomography in the detection of malignant degeneration of low-grade gliomas (1989) J. Neurosurg., 24, pp. 1-5
Fulham, M.J., Bizzi, A., Dietz, M.J., Mapping of brain tumor metabolites with proton MR spectroscopic imaging: Clinical relevance (1992) Radiology, 185, pp. 675-686
Fulham, M.J., Brunetti, A., Aloj, L., Decreased cerebral glucose metabolism in patients with brain tumors: An effect of corticosteroids (1995) J. Neurosurg., 83, pp. 657-664
Gadian, D.G., (1982) Nuclear Magnetic Resonance and Its Application to Living Systems, , Clarendon Press, Oxford
Gallen, C.C., Sobel, D.F., Levine, J.D., Neuromagnetic mapping of brain function (1993) Radiology, 187, pp. 863-869
Giangaspero, F., Burger, P.C., Correlations between cytologic composition and biologic behavior in the glioblastoma multiforme (1983) Cancer, 52, pp. 2320-2333
Ginos, J.Z., Cooper, A.J.L., Dhawan, V., [N-13]Cisplatin PET to assess pharmacokinetics of intra-arterial versus intravenous chemotherapy for malignant brain tumors (1987) J. Nucl. Med., 28, pp. 1844-1852
Glantz, M.J., Hoffman, J.M., Coleman, R.E., Identification of early recurrence of primary central nervous system tumors by [18F]-fluorodeoxyglucose positron emission tomography (1991) Ann. Neurol., 29, pp. 347-355
Goldstein, L.J., Galsh, H., Fojo, A., Expression of a multidrug resistance gene in human cancers (1989) J. Natl. Cancer. Inst., 81, pp. 116-124
Graham, J.F., Cummins, C.J., Smith, B.K., Kornblith, P.L., Regulation of hexokinase in cultured gliomas (1985) Neurosurgery, 17, pp. 537-542
Greitz, T., Bohm, C., Holte, S., Eriksonn, L., A computerized brain atlas: Construction, anatomical content and some applications (1991) J. Comput. Assist. Tomogr., 15, pp. 26-32
Hagberg, G., Burlina, A.P., Mader, I., In vivo proton MR spectroscopy of human gliomas: Definition of metabolic coordinates for multidimensional classification (1995) Magn. Reson. Med., 34, pp. 242-252
Haldemann, A.R., Roesler, H., Barth, A., Somatostatin receptor scintigraphy in central nervous system tumors: Role of blood-brain-barrier permeability (1995) J. Nucl. Med., 36, pp. 403-410
Hämäläinen, M., Hari, R., Ilmoniemi, R., Magnetoencephalography: Theory, instrumentation and applications to noninvasive studies of the working human brain (1993) Rev. Mod. Phys., 65, pp. 413-497
Hanson, M.W., Glantz, M.J., Hoffman, J.M., FDG-PET in the selection of brain lesions for biopsy (1991) J. Comput. Assist. Tomogr., 15, pp. 796-801
Hatazawa, J., Ishiwata, K., Itoh, M., Quantitative evaluation of L-[methyl-11C]-methionine uptake in tumor using positron emission tomography (1989) J. Nucl. Med., 30, pp. 1809-1813
Hawkins, R.A., Phelps, M.E., Huang, S.-C., A kinetic evaluation of blood-brain barrier permeability in human brain tumors with [68Ga] EDTA and positron computed tomography (1984) J. Cereb. Blood Flow Metab., 4, pp. 507-515
Heindel, W., Bunke, J., Glathe, S., Combined 1H-MR-imaging and localized 31P spectroscopy of intracranial tumors in 43 patients (1988) J. Comput. Assist. Tomogr., 12, pp. 907-916
Heiss, W.-D., Heindel, W., Herholz, K., Positron emission tomography of fluorine-18-deoxyglucose and image-guided phosphorus-31 magnetic resonance spectroscopy in brain tumors (1990) J. Nucl. Med., 31, pp. 302-310
Herholz, K., Wienhard, K., Heiss, W.-D., Validity of PET studies of brain tumors (1990) Cerebrovasc. Brain Metab. Rev., 2, pp. 240-265
Herholz, K., Heindel, W., Luyten, P.R., In vivo imaging of glucose consumption and lactate concentration in human gliomas. Ann (1992) Neurol., 31, pp. 319-327
Hiesiger, E., Fowler, J.S., Wolf, A.P., Serial PET studies of human cerebral malignancy with [1-11C]-putrescine and [1-11C]-2-deoxy-glucose (1987) J. Nucl. Med., 28, pp. 1251-1261
Higashi, K., Clavo, A.C., Wahl, R.L., Does FDG uptake measure proliferative activity of human cancer cells? in vitro comparison with DNA flow cytometry and tritiated thymidine uptake (1993) J. Nucl. Med., 34, pp. 414-419
Hildebrand, J., Treatment of primary brain tumors (1992) Management in Neuro-oncology, pp. 3-22. , (Edited by Hildebrand J.). Springer-Verlag, New York
Hisada, K., Tonami, N., Miyamae, T., Clinical evaluation of tumor imaging with 201Tl chloride (1978) Radiology, 129, pp. 497-500
Hoffman, J.M., Hanson, M.W., Friedman, H.S., FDG-PET in pediatric posterior fossa brain tumors (1992) J. Comput. Assist. Tomogr., 16, pp. 62-68
Hoffman, J.M., Waskin, H.A., Schifter, T., FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS (1993) J. Nucl. Med., 34, pp. 567-575
Holman, B.L., Carvalho, P.A., Zimmermann, R.E., Brain perfusion SPECT using an annular single crystal camera: Initial clinical experience (1990) J. Nucl. Med., 31, pp. 1456-1461
Holman, B.L., Hellman, R.S., Goldsmith, S.J., Computerassisted superimposition of magnetic resonance and high-resolution 99mTc HMPAO and 201Tl SPECT images (1991) J. Nucl. Med., 32, pp. 1478-1484
Howe, F.A., Canese, R., Podo, F., Quality assessment in vivo NMR spectroscopy: V. Multicentre evaluation of prototype test objects and protocols for performance assessment in small-bore MRS equipment of MRS test signals (1995) Magn. Reson. Imaging, 13, pp. 159-167
Hubesch, B., Sappey-Marinier, D., Roth, K., P-31 MR spectroscopy of normal human brain and brain tumors (1990) Radiology, 174, pp. 401-409
Hurtt, M.R., Moossy, J., Donovan Peluso, M., Locker, J., Amplification of epidermal growth factor receptor gene in gliomas: Histopathology and prognosis (1992) J. Neuropathol. Exp. Neuro., 51, pp. 84-90
Iannotti, F., Fieschi, C., Alfano, B., Simplified noninvasive PET measurement of blood-brain-barrier permeability (1987) J. Comput. Assist. Tomogr., 11, pp. 390-396
Isen, H.W., Sato, M., Pawlik, 68Ga-EDTA positron emission tomography in the diagnosis of brain tumors (1984) Neuroradiolagy, 26, pp. 393-398
Ishiwata, K., Kubota, K., Murakami, M., Re-evaluation of amino-acid PET studies: Can the protein synthesis rates in brain and tumor tissues by measured in vivo? (1993) J. Nucl. Med., 34, pp. 1936-1943
Ishizu, K., Nishizawa, S., Yonekura, Y., Effects of hyperglycemia on FDG uptake in human brain and glioma (1994) J. Nucl. Med., 35, pp. 1104-1109
Ishizu, K., Sadato, N., Yonekura, Y., Enhanced detection of brain tumors by [18F]-fluorodeoxyglucose PET with glucose loading (1994) J. Comput. Assist. Tomogr., 18, pp. 12-15
Jack, C.R., Thompson, R.M., Butts, R.K., Sensory motor cortex: Correlation of presurgical mapping with functional MR imaging and invasive cortical mapping (1994) Radiology, 190, pp. 85-92
James, C.D., Collins, V.P., Molecular genetic characterization of CNS tumor oncogenesis (1992) Adv. Cancer Res., 58, pp. 121-142
Jarden, J.O., Dhawan, V., Poltorak, A., PET measurement of blood-to-brain and blood-to-tumor transport of Rb-82: The effect of desamethasone and whole brain radiation therapy (1985) Ann. Neurol., 18, pp. 636-646
Jinnouchi, S., Hoshi, H., Ohnishi, T., Thallium-201 SPECT for predicting histological types of meningiomas (1993) J. Nucl. Med., 34, pp. 2091-2094
Jones, S., Hendel, R.C., Technetium-99m tetrofosmin: A new myocardial perfusion agent (1993) J. Nucl. Med. Technol., 21, pp. 191-195
Junck, L., Olson, J.M.M., Ciliax, B.J., PET imaging of human gliomas with ligands for the peripheral benzodiazepine receptors (1989) Ann. Neurol, 26, pp. 752-758
Kahn, D.A., Follett, K.A., Bushnell, D.L., Diagnosis of recurrent brain tumor: Value of 201Tl SPECT vs. 18F-fluorodeoxyglucose PET (1994) AJR, 163, pp. 1459-1463
Kaplan, W.D., Takvorian, T., Morris, J.H., Thallium-201 brain tumor imaging: A comparative study with pathologic correlation (1987) J. Nucl. Med., 28, pp. 47-52
Kapoor, R., Spence, A.M., Muzi, M., Determination of the deoxyglucose and glucose phosphorylation ratio and the lumped-constant in rat brain and a transplantable rat glioma (1989) J. Neurochem., 53, pp. 37-44
Kasarov, L.B., Friedman, H., Enhanced Na+-K+ activated adenosine triphosphatase activity in transformed fibroblasts (1974) Cancer Res., 34, pp. 1862-1865
Kato, A., Diksic, M., Yamamoto, Y.L., Feindel, W., Quantification of glucose utilization in an experimental brain tumor model by the deoxyglucose method (1985) J. Cereb. Blood Flow Metab., 5, pp. 108-114
Keevil, S.F., Barbiroli, B., Collins, D.J., Quality assessment in in vivo NMR spectroscopy: IV. A multicentre trial of test objects and protocols for performance assessment in clinical NMR spectroscopy (1995) Magn. Reson. Imaging, 13, pp. 139-157
Kelly, J.D., Forster, A.M., Higley, B., Technetium-99m-tetrofosmin as a new radio-pharmaceutical for myocardial perfusion imaging (1993) J. Nucl. Med., 34, pp. 222-227
Kessler, R.M., Goble, J.C., Bird, J.H., Measurement of blood-brain barrier permeability with PET and Ga-68 EDTA (1984) J. Cereb. Blood Flow Metab., 4, pp. 323-328
Kim, K., Black, K.L., Marciano, D., Thallium-201 SPECT imaging of brain tumors: Methods and results (1990) J. Nucl. Med., 31, pp. 965-969
Kim, C.K., Alavi, J.B., Alavi, A., New grading system of cerebral gliomas using positron emission tomography and F-18 fluorodeoxyglucose (1991) J. Neurooncol., 10, pp. 85-91
Kim, D.K., Hoyt, J., Bacchi, C., Detection of proliferating cell nuclear antigen in gliomas and adjacent resection margins (1993) Neurosurgery, 33, pp. 619-625
Kleihues, P., Burger, P.C., Scheithauer, B.W., The new WHO classification of brain tumors (1993) Brain Pathol., 3, pp. 255-268
Kooy, H.M., Van Herke, M., Barnes, P.D., Image fusion for stereotactic radiotherapy and radiosurgery treatment planning (1994) Int. J. Radiat. Oncol. Biol. Phys., 28, pp. 1229-1234
Korkolopoulou, P., Christodoulou, P., Lekka-Katsouli, I., Prognostic significance of proliferating cell nuclear antigen (PCNA) expression in gliomas (1994) Histopathology, 25, pp. 349-355
Kosuda, S., Fujii, H., Aoki, S., Prediction of survival in patients with suspected recurrent cerebral tumors by quantitative thallium-201 single-photon emission computed tomography (1994) Int. J. Radiat. Oncol. Biol. Phys., 30, pp. 1201-1206
Kubota, K., Ishiwata, K., Kubota, R., Tracer feasibility for monitoring tumor radiotherapy: A quadruple tracer study with fluorine-18-fluorodeoxyglucose or fluroine-18-fluorodeoxyuridine, L-[methyl-14C]methionine, [6-3H]thymidine and gallium-67 (1991) J. Nucl. Med., 32, pp. 2118-2123
Kubota, K., Yamada, S., Kubota, R., Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: High accumulation in macrophages and granulation tissue studied with microautoradiography (1992) J. Nucl. Med., 33, pp. 1972-1980
Kubota, R., Kubota, K., Yamada, S., Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake (1993) J. Nucl. Med., 35, pp. 104-112
Kuwabara, Y., Ichiya, Y., Otsuka, M., High [18F] FDG uptake in primary cerebral lymphoma - A PET study (1988) J. Comput. Assist. Tomogr., 12, pp. 47-48
Lamberts, S.W.J., Krenning, E.P., Reubi, J.C., The role of somatostatin and its analogs in the diagnosis and treatment of tumors (1991) Endocr. Rev., 12, pp. 450-482
Lammertsma, A.A., Wise, R.J.S., Cox, T.C.S., Measurement of blood flow, oxygen utilization, oxygen extraction ratio and fractional blood-volume in human brain tumors and surrounding oedematous tissue (1985) Br. J. Radiol., 58, pp. 725-734
Langen, K.J., Roosen, N., Herzog, H., Investigations of brain tumors with 99mTc-HMPAO SPECT (1989) Nucl. Med. Commun., 10, pp. 325-334
Langen, K.J., Coenen, H.H., Roosen, N., SPECT studies of brain tumors with L-3-(123I)iodo-α-methyl tyrosine: Comparison with PET 124I MT and first clinical results (1990) J. Nucl. Med., 31, pp. 281-286
Latchaw, R.E., Johnson, D.W., Kanal, E., Cranial and intracranial neoplasm (1991) MR and CT Imaging of the Head, Neck and Spine, 1, pp. 450-471. , Edited by Latchaw R. E., Mosby, St. Louis
Leach, M.O., Collins, D.J., Keevil, S., Quality assessment in in vivo NMR spectroscopy: III. Clinical test objects: Design construction and solutions (1995) Magn. Reson. Imaging, 13, pp. 131-137
Lear, J.L., Glycolysis link between PET and proton MR spectroscopic studies of the brain (1990) Radiology, 174, pp. 328-330
Lee, J.D., Kim, D.I., Lee, J.T., Chang, J.W., Park, C.Y., Indium-111-pentetreotide imaging in intra-axial brain tumors: Comparison with thallium-201 SPECT and MRI (1995) J. Nucl Med., 36, pp. 537-541
Leibel, S.A., Scott, C.B., Loeffler, J.S., Contemporary approaches for the treatment of malignant gliomas with radiation therapy (1994) Semin. Oncol., 21, pp. 198-219
Leichner, P.K., Morgan, H.T., Holdeman, K.P., SPECT imaging of fluorine-18 (1995) J. Nucl. Med., 36, pp. 1472-1475
Lenkinski, R.E., Holland, G.A., Allman, T., Integrated mr imaging and spectroscopy with chemical shift imaging of 31P at 1.5 T: Initial clinical experience (1988) Radiology, 169, pp. 201-206
Lilja, A., Bergström, K., Hartvig, P., Dynamic studies of supratentorial gliomas with L-methyl-11C-methionine (1985) AJNR, 6, pp. 605-614
Lucignani, G., Schmidt, K.C., Moresco, R.M., Measurement of regional cerebral glucose utilization with fluorine-18-FDG and PET: Theoretical consideration and practical procedures (1992) J. Nucl. Med., 34, pp. 360-369
Lucignani, G., Rizzo, G., Triulzi, F., Non-invasive brain imaging techniques (SPET, PET, and MRI): Relative merits and synergistic use (1993) New Trends in Nuclear Neurology and Psychiatry, pp. 133-149. , (Edited by Costa D. C., Morgan G. F. and Lassen N. A.). J. Labbey, London
Luyten, P.R., Marien, A.J.H., Heindel, W., Metabolic imaging of patients with intracranial tumors: H1-MR spectroscopic imaging and PET (1990) Radiology, 176, pp. 791-799
Macfarlane, D.J., Cotton, L., Ackermann, R.J., Triple-head SPECT with 2-fluorine-18-fluoro-2-deoxy-D-glucose (FDG): Initial evaluation in oncology and comparison with FDG-PET (1995) Radiology, 194, pp. 425-429
Maeda, M., Itoh, I., Kimura, H., Tumor vascularity in the brain: Evaluation with dynamic susceptibility-contrast MR imaging (1993) Radiology, 189, pp. 233-238
Martin, W.H., Delbeke, D., Patton, J.A., FDG-SPECT: Correlation with FDG-PET (1995) J. Nucl. Med., 36, pp. 988-995
McComb, R.D., Bigner, D.D., The biology of malignant gliomas - A comprehensive study (1984) Clin. Neuropathol., 3, pp. 93-106
Meyer, G.J., Schober, O., Evaluation of brain rumors by PET (1991) Radiopharmaceuticals and Brain Pathology Studied with PET and SPECT, pp. 303-336. , (Edited by Diksic M. and Reba R. C.). CRC Press, Boca Raton, FL
Mikkelsen, T., Genetics of astrocytic tumor progression (1993) Mol. Genet. Med., 3, pp. 69-94
Mikkelsen, T., Yan, P.-S., Ho, K.-H., Immunolocalization of cathepsin B in human glioma: Implications for tumor invasion and angiogenesis (1995) J. Neurosurg., 83, pp. 285-290
Mmeura, K., Yashuda, T., Kowada, M., PET evaluation of histologic malignancy in gliomas using oxygen-15 and fluorine-18-fluorodeoxyglucose (1986) Neurol. Res., 8, pp. 164-168
Mineura, K., Kowada, M., Shishido, F., Brain tumor imaging with synthesized [18F]-fluorophenylaianine and positron emission tomography (1989) Surg. Neurol., 31, pp. 468-469
Mineura, K., Sasajima, T., Kowada, M., Perfusion and metabolism in predicting the survival of patients with cetebral gliomas (1994) Cancer, 73, pp. 2386-2394
Minn, H., Joensuu, H., Ahonen, A., Klemi, P., Fluorodeoxyglucose imaging: A method to assess the proliferarive activity of human cancer in vivo - Comparison with DNA-flow-cytometry in head and neck tumors (1988) Cancer, 61, pp. 1776-1781
Moats, R.A., Watson, L., Shonk, T., Added value of automated clinical proton spectroscopy of the brain (1995) J. Comput. Assist. Tomogr., 19, pp. 480-491
Mogard, J., Kihlstroem, L., Ericson, K., Recurrent tumor vs. Radiation: Effects after gamma knife radiosurgery of intracerebral metastases: Diagnosis with PET-FDG (1994) J. Comput. Assist. Tomogr., 18, pp. 177-181
Mosskin, M., Von Holst, H., Bergström, M., Positron emission tomography with 11C-methionine and computed tomography of intracranial tumors compared with histopathoiogical evaluation of multiple biopsies (1987) Acta Radiol., 28, pp. 673-681
Mountz, J.M., Raymond, P.A., McKeever, P.E., Specific localization of thallium-201 in high-grade astrocytoma by microautoradiography (1989) Cancer Res., 49, pp. 4053-4056
Mountz, J.M., Stafford-Schuck, K., McKeever, P.E., Taver, J., Beierwaltes, W.H., Thallium-201 tumor/cardiac ratio estimation of residual astrocytoma (1989) J. Neurosurg., 68, pp. 705-709
Mountz, J.M., Deutsch, G., Kuzniecky, R., Rosenfeld, S.S., Brain SPECT: An update (1994) Nuclear Medicine Annual, pp. 1-54. , (Edited by Freeman L. M.). Raven Press, New York
Nadel, H.R., Thallium-201 for oncological imaging in children (1993) Semin. Nucl. Med., 23, pp. 243-254
Nakano, S., Kinoshita, K., Jinnouchi, S., Dynamic SPECT iodine-123 IMP in meningiomas (1988) J. Nucl. Med., 29, pp. 1627-1632
Nakano, A., Tani, E., Miyazaki, K., Matrix metalloprotein ases and tissue inhibitors of metalloproteinases in human gliomas (1995) J. Neurosurg., 83, pp. 298-307
Narayana, P.A., Johnston, D., Flamig, D.P., In vivo proton magnetic resonance spectroscopy studies of human brain (1991) Magn. Reson. Imaging, 9, pp. 303-308
Naruse, S., Horikawa, Y., Tanaka, C., Evaluation of the effects of photoradiation therapy on brain tumors with in vivo 31MR spectroscopy (1986) Radiology, 160, pp. 827-830
Negendank, W.G., Studies of human tumors by MRS: A review (1992) NMR Biomed, 5, pp. 3903-3904
Negendank, W.G., Brown, T.R., Eveloch, J.L., Proceedings of a National Cancer Institute workshop: MR spectroscopy (1992) Radiology, 185, pp. 875-883
Noz, M.E., Maguire, G.Q., Multimodality image correlation and fusion (1995) Clinical SPECT Imaging, pp. 79-95. , (Edited by Kramer E. L. and Sanger J. J.). Raven Press, New York
Ogawa, S., Lee, T.M., Kay, A.R., Brain magnetic resonance imaging with contrast dependent on blood oxygenation (1990) Proc. Natl. Acad. Sci. USA, 87, pp. 9868-9872
Ogawa, T., Uemura, K., Shishido, F., Changes of cerebral blood flow and oxygen and glucose metabolism following radiochemotherapy of gliomas - A PET study (1988) J. Comput. Assist. Tomogr., 12, pp. 290-297
Ogawa, T., Kanno, I., Shishido, F., Clinical value of PET with 18F-fluorodeoxyglucose and L-methyl-11C-methionine for diagnosis of recurrent brain tumor and radiation injury (1991) Acta Radiol., 32, pp. 197-202
O'Malley, J.P., Ziessman, H.A., Kumar, P.N., Diagnosis of intracranial lymphoma in patients with AIDS: Value of 201Tl single-photon emission computed tomography (1994) AJR, 163, pp. 217-221
Oriuchi, N., Tamura, M., Shibazake, T., Clinical evaluation of thallium-201 SPECT in supratentorial gliomas: Relationship to histologic grade, prognosis and proliferative activity (1993) J. Nucl. Med., 34, pp. 2085-2089
Osborn, A.G., (1994) Diagnostic Neuroradiology, , Mosby, St. Louis
Otsuki, H., Brunetti, A., Owens, E.S., Finn, R.D., Blasberg, R.G., Comparison of iron-59, indium-111, gallium-68 transferrin as a macromolecular tracer of vascular permeability and the transferrin receptor (1989) J. Nucl. Med., 30, pp. 1676-1685
O'Tuama, L.A., Philips, P.C., Strauss, L.C., Two-phase [11C]-L-methionine PET in childhood brain tumors (1991) Pediatr. Neurol., 6, pp. 163-170
O'Tuama, L.A., Treves, S.T., Larar, J.N., Thallium-201 versus technetium-99m-MIBI SPECT in evaluation of childhood brain tumors: A within-subject comparison (1993) J. Nucl. Med., 34, pp. 1045-1051
Ott, D., Hennig, J., Ernst, T., Human brain tumors: Assessment with in vivo proton MR spectroscopy (1993) Radiology, 186, pp. 745-752
Packard, A.B., Kronauge, J.F., Limpa-Amara, N., Tumor uptake of 99mTc-MIBI and 201Tl by a 9L gliosarcoma brain tumor model in rats (1993) Nucl. Med. Biol., 20, pp. 773-776
Park, C.H., Kim, S.M., Zhang, J.J., Intenzo, C.M., McEwan, J.R., Tc-99m MIBI brain SPECT in the diagnosis of recurrent glioma (1994) Clin. Nucl. Med., 19, pp. 57-58
Patronas, N.J., Di Chiro, G., Brooks, R.A., Fluonne-18-fluorodeoxyglucose and positron emission tomography in evaluation of radiation necrosis of the brain (1982) Radiology, 144, pp. 885-889
Paulus, W., Pfeiffer, J., Intratumoral histologic heterogeneity of gliomas (1989) Cancer, 64, pp. 442-447
Pellizzari, C.A., Chen, G.T.Y., Spelbring, D.R., Accurate three-dimensional registration of CT, PET and/or MR images of the brain (1988) J. Comput. Assist. Tomogr., 13, pp. 20-26
Rao, V.V., Chiu, M.L., Kronauge, J.F., Piwnica-Worms, D., Expression of recombinant human multidrug resistance p-glycoprotein in insect cells confers decreased accumulation of technetium-99m-sestamibi (1994) J. Nucl. Med., 35, pp. 510-515
Reivich, M., Kuhl, D., Wolf, A., The 18F-fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man (1979) Cir. Res., 44, pp. 127-137
Piwnica-Worms, D., Chiu, M.L., Budding, M., Kronauge, J.F., Kramer, F.A., Croop, J.M., Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex (1993) Cancer Res., 53, pp. 1-8
Podo, F., Bovee, W.M.M.J., De Certaines, J., Quality assessment in in vivo MR spectroscopy: Introduction, objectives and activities (1995) Magn. Reson. Imaging, 13, pp. 117-121
Ritter, A.M., Sawaya, R., Hess, K.R., Levin, V.A., Bruner, J.M., Prognostic significance of bromodeoxyuridine labeling in primary and recurrent glioblastoma multiforme (1994) Neurosurgery, 35, pp. 192-198
Rhodes, C.G., Wide, R.J.S., Gibb, J.M., In vivo disturbance of oxidative metabolism of glucose in human cerebral gliomas (1983) Ann. Neurol., 14, pp. 614-626
Rosen, B.R., Belliveau, J.W., Aaronen, H., Susceptibility contrast imaging of cerebral blood volume: Human experience (1991) Magn. Reson. Med., 22, pp. 293-299
Rosen, B.R., Aaronen, H., Kwong, K., Advances in clinical neuroimaging: Functional MR imaging techniques (1993) Radiographics, 13, pp. 889-896
Ross, B.D., Tropp, J., Derby, K.A., Metabolic response of glioblastoma to adoptive immunotherapy: Detection by phosphorus MR spectroscopy (1989) J. Comput. Assist. Tomogr., 13, pp. 189-193
Ross, B., Michaelis, T., Clinical applications of magnetic resonance spectroscopy (1994) Magn. Reson Q., 10, pp. 191-247
Rottenberg, D.A., Ginos, J.Z., Kearfott, K.J., In vivo measurement of brain tumor pH using C-11 DMO and positron emission tomography (1985) Ann. Neurol., 17, pp. 70-75
Ruiz, A., Ganz, W.J., Post, M.J.D., Use of thallium-201-SPECT to differentiate cerebral lymphomas from toxoplasma encephalitis in AIDS patients (1994) AJNR, 15, pp. 1885-1894
Russel, D.L., Rubinstein, L.J., (1985) Pathology of the Tumors of the Nervous System, 5th Edn., , Williams and Wilkins, Baltimore
Salmon, I., Kiss, R., Dewitte, O., Histopathologic grading and DNlA ploidy in relation to survival among 206 adult astrocytic tumors (1992) Cancer, 70, pp. 538-546
Salvatore, M., Carratù, L., Porta, E., Thallium-201 as a positive indicator for lung neoplasms: Preliminary experiments (1976) Radiology, 121, pp. 487-488
Schenk, J.F., Jolesz, F.A., Roemer, P.B., Superconducting open-configuration MR imaging system for image-guided therapy (1995) Radiology, 195, pp. 805-814
Schober, O., Meyer, G.J., Stolke, D., Hundeshagen, H., Brain tumor imaging using C-11-labeled L-methionine and D-methionine (1985) J. Nucl. Med., 26, pp. 98-99
Schiffer, D., Chiö, A., Giordana, M.T., Prognostic value of histologic factors in adult cerebral astrocytoma (1988) Cancer, 61, pp. 1386-1393
Schifter, T., Hoffman, J.M., Hanson, M.W., Serial FDG-PET studies in the prediction of survival in patients with primary brain tumors (1993) J. Comput. Assist. Tomogr., 17, pp. 509-561
Schwartz, R., Carvalho, P.A., Alexander E. III, Loeffler, J.S., Folkerth, R., Holman, B.L., Radiation necrosis vs. High-grade recurrent glioma: Differentiation by using dual-isotope SPECT with 201Tl and 99mTc-HMPAO (1991) AJNR, 12, pp. 1187-1192
Segerbarth, C.M., Baleriaux, D.F., Arnold, D.L., Luyten, P.R., Den Hollander, J.A., MR image-guided P-31 MR spectroscopy in the evaluation of brain tumor treatment (1987) Radiology, 165, pp. 215-219
Sehweil, A., McKillop, J.H., Ziada, G., The optimum time for tumor imaging with thallium-201 (1988) Eur. J. Nucl. Med., 13, pp. 527-529
Sijens, P.E., Knopp, M.V., Brunetti, A., 1H MR spectroscopy in patients with metastatic brain tumors: A multi-center study. Magn (1995) Reson. Med., 33, pp. 818-826
Slizofski, W.J., Krishna, L.K., Katsetos, C.D., Thallium imaging for brain tumors with results measured by semiquantitative index and correlated with histopathology (1994) Cancer, 74, pp. 3190-3197
Slosman, D.O., Pugin, J., Lack of correlation between tritiated-deoxyglucose, thallium-201 and technetium-99m-MIBI cell incorporation under various cell stresses (1994) J. Nucl. Med., 35, pp. 120-126
Sneed, P.K., Larson, D.A., Gutin, P.H., Brachytherapy ancd hyperthermia for malignant astrocytoma (1994) Semin. Oncol., 21, pp. 186-197
Sokoloff, L., Reivich, M., Kennedy, C., The [14C]-deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure and normal values in the conscious and anesthesized albino rat (1977) J. Neurochem., 28, pp. 897-916
Starosta-Rubinstein, S., Ciliax, B.J., Penney, J.B., Imaging of glioma using peripheral benzodiazepine receptor ligands (1987) Proc. Natl. Acad. Sci. USA, 84, pp. 891-895
Suess, E., Malessa, S., Ungersbock, K., Technetium-99m-d,l-hexamethylpropyleneamine oxime (HMPAO) uptake and glutathione content in brain tumors (1991) J. Nucl. Med., 31, pp. 1675-1681
Suhonen-Polvi, H., Ruotsalainen, U., Kinnala, A., FDG-PET in early infancy: Simplified quantification methods to measure cerebral glucose utilization (1995) J. Nucl. Med., 36, pp. 1249-1254
Sutton, L.N., Wang, Z., Gusnard, D., Proton magnetic resonance spectroscopy of pediatric brain tumors (1992) Neurosurgery, 31, pp. 195-202
Thomsen, C., Jensen, K.E., Achten, E., Iin vivo magnetic resonance imaging and 31P spectroscopy of large human brain tumours at 1.5 T (1988) Acta Radiol., 29, pp. 77-82
Tjuvajev, J.G., Macapinlac, H.A., Daghighian, F., Imaging of brain tumor proliferative activity with iodine-131-iodeoxyuridine (1994) J. Nucl. Med., 35, pp. 1407-1417
Townsend, D.W., Geissbuhler, A., Defrise, M., Fully three-dimensional reconstruction for a PET camera with retractable septa (1991) IEEE Trans. Med. Imaging, 10, pp. 505-512
Tsukiyama, T., Hara, T., Iio, M., Preferential accumulation of 11C in human brain tumors after intravenous injection of 11C-l-pyruvate (1986) Eur. J. Nucl. Med., 12, pp. 244-248
Tsurumi, Y., Kameyama, M., Ishiwata, K., 18F-Fluoro-2′-deoxyuridine as a tracer of nucleic acid metabolism in brain tumors (1990) J. Neurosurg., 72, pp. 1110-1113
Turkington, T.G., Hoffman, J.M., Jaszczak, R.J., Accuracy of surface fit registration for PET and MR brain images using full and incomplete brain surfaces (1995) J. Comput. Assist. Tomogr., 19, pp. 117-124
Tyler, J.L., Yamamoto, Y.L., Diksic, M., Pharmacokinetics of superselective intrarterial and intravenous 11C-BCNU evaluated with PET (1986) J. Nucl. Med., 27, pp. 775-780
Tyler, J.L., Diksic, M., Villemure, J.G., Metabolic and hemodynamic evaluation of gliomas using PET (1987) J. Nucl. Med., 28, pp. 1123-1133
Ueda, T., Kaji, Y., Wakisaka, S., Time sequential single photon emission tomography studies in brain tumors using thallium-201 (1993) Eur. J. Nucl Med., 20, pp. 138-145
Valk, P.E., Budinger, T.F., Levin, P.A., PET of malignant cerebral tumors after interstitial brachytherapy: Demonstration of metabolic activity and correlation with clinical outcome (1988) J. Neurosurg., 69, pp. 830-838
Venuta, S., Ferraiuolo, R., Morrone, G., The uptake of Tl-201 in normal and transformed thyroid cell lines (1979) J. Nucl. Med. Allied Sci., 23, pp. 163-166
Van Der Borght, T., Pauwels, S., Lambotte, L., Brain tumor imaging with PET and 2-[carbon-11]-thymidine (1994) J. Nucl. Med., 35, pp. 974-982
Van Der Eisen, P.A., Pol, E.J.D., Viergever, M.A., Medical image matching: A review with classification (1993) IEEE Eng. Med. Biol., 40, pp. 26-39
Viale, G.L., Biochemical patterns in brain tumors: I. Enzymes of glycolysis (1969) Acta Neurochir., 20, pp. 263-272
Wackers, F.J., Berman, D.S., Maddahi, J., Tc-99m hexakis 2-methoxyisobutylisonitrile: Human biodistribution, dosimetry, safety and preliminary comparison to thallium-201 for myocardial perfusion imaging (1989) J. Nucl. Med., 31, pp. 301-311
Wagner H.N., Jr., Burns, H.D., Dannals, R.F., Imaging dopamine receptors in the human brain by positron emission tomography (1983) Science, 221, pp. 1264-1266
Walker, A.E., Robins, M., Weinfeld, F.D., Epidemiology of brain tumors: The national survey of intracranial neoplasms (1985) Neurology, 35, pp. 219-226
Warburg, O., (1926) Über den Stoffwechsel der Tumoren (On the Metabolism of Tumors), , Springer-Verlag, Berlin
Watanabe, A., Tanaka, R., Takeda, N., Washiyama, K., DNA synthesis, blood flow and glucose utilization in experimental rat brain tumor (1989) J. Neurosurg., 70, pp. 86-91
Watanabe, M., Tanaka, R., Takeda, N., Magnetic resonance imaging and histopathology of cerebral gliomas (1992) Neuroradiology, 34, pp. 463-469
Waxman, A.D., Thallium-201 in nuclear oncology (1991) Nuclear Medicine Annual, pp. 193-209. , (Edited by Freeman L. M.). Raven Press, New York
Wienhard, K., Heroltz, K., Coenen, H.H., Increased amino acid transport into brain tumors measured by PET and L[2-18F]fluorothyrosine (1991) J. Nucl. Med., 32, pp. 1338-1346
Willemsen, A.T.M., Van Waarde, A., Paans, A.M.J., In vivo protein synthesis rate determination in primary or recurrent brain tumors using L-[1-11C]-tyrosine and PET (1995) J. Nucl. Med., 36, pp. 411-419
Woods, R.P., Mazziotta, J.C., Cherry, S.R., MRI-PET registration, with automated algorithm (1993) J. Comput. Assist. Tomogr., 17, pp. 536-546
Wu, H.-M., Huang, S.-C., Choi, Y., Hoh, C.K., Hawkins, R.A., A modeling method to improve quantitation of fluorodeoxyglucose uptake in heterogeneous tissue (1995) J. Nucl. Med., 36, pp. 297-306
Yen, C.K., Yano, Y., Budinger, T.F., Brain tumor evaluation using Rb-82 and PET (1982) J. Nucl. Med., 23, pp. 532-537
Yoshii, Y., Maki, Y., Tsuboi, K., Estimation of growth fraction with bromodeoxyuridine in human CNS tumors (1986) J. Neurosurg., 65, pp. 659-663
Yoshii, Y., Satou, M., Yamamoto, T., The role of thallium-201 single photon emission tomography in the investigation and characterisation of brain tumors in man and their response to treatment (1993) Eur. J. Nucl. Med., 20, pp. 39-45
Yoshioka, T., Takahashi, H., Oikawa, H., Accumulation of 2-deoxy-2[11F]fluoro-D-glucose in human cancers heterotransplanted in nude mice: Comparison between histology and glycolitic studies (1994) J. Nucl. Med., 35, pp. 97-103
Zanzonico, P., Technical requirements for SPECT: Instrumentation, data acquisition and processing, and quality control (1995) Clinical SPECT Imaging, pp. 7-41. , (Edited by Kramer E. L. and Sanger J. J.). Raven Press, New York
Zhang, J.J., Park, C.H., Kim, S.M., Ayyangar, K.M., Haghbin, M., Dual isotope SPECT in the evaluation of recurrent brain tumor (1991) Clin. Nucl. Med., 17, pp. 663-664
Zimmermann, R.A., Bottomley, P.A., Edelstein, W.A., Proton imaging and phosphorus spectroscopy in a malignant glioma (1985) AJNR, 6, pp. 109-110
Zülch, K.J., (1979) Histology Typing of Tumors of the Central Nervous System, , World Health Organization, Geneva
Aaronen, H. J., Gazit, I. E., Louis, D. N., Cerebral blood volume maps of gliomas: Comparison with tumor grade and histologic findings (1994) Radiology, 191, pp. 41-5
Alger, J. R., Frank, J. A., Bizzi, A., Metabolism of human gliomas: Assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET (1990) Radiology, 177, pp. 633-641
Alger, J. R., Symko, S. C., Bizzi, A., Absolute quantitation of short TE brain 1H-MR spectra and spectroscopic imaging data (1993) J. Comput. Assist. Tomogr., 17, pp. 191-199
Alavi, J. B., Alavi, A., Chawluk, J., Positron emission tomography in patients with glioma - A predictor of prognosis (1988) Cancer, 62, pp. 1074-1078
Andersson, J. L. R., Sundin, A., Valind, S., A method for coregistration of PET and MR brain images (1995) J. Nucl. Med., 36, pp. 1307-1315
Babich, J. W., Keeling, F., Flower, M. A., Initial experience with Tc-99m-HMPAO in the study of brain tumors (1988) Eur. J. Nucl. Med., 14, pp. 34-44
Behars, O. H., Henson, D. E., Hutter, R. V. P., Myers, M. H., (1988) Manual for Staging Cancer (AJCC), , Lippincott, Philadelphia
Bentson, J. R., Steckel, R. J., Kagan, A. R., Diagnostic imaging in clinical cancer management: Brain metastases (1988) Invest. Radiol., 23, pp. 335-341
Berger, M. S., Malignant astrocytomas: Surgical aspects (1994) Semin. Oncol., 21, pp. 172-185
Bergstr m, M., Collins, V. P., Ehrin, E., Discrepancies in brain tumor extent as shown by CT and PET using (68Ga) EDTA, (11C) glucose and (11C) methionine (1983) J. Comput. Assist. Tomogr., 7, pp. 1062-1066
Bergstr m, M., Ericson, K., Hagenfeld, L., Studies of methionine accumulation in glioma and normal brain tissue: Competition with branched-chain amino acids (1987) J. Comput. Assist. Tomogr., 11, pp. 208-213
Bergstr m, M., Lundqvist, H., Ericson, A., Comparison of the accumulation kinetics of L- (methyl-11C) -methionine and D- (methyl-11C) -methionine in brain tumors studied with positron emission tomography (1987) Acta Radiol., 28, pp. 225-229
Bergstr m, M., Muhr, C., Lundberg, P. O., Rapid decrease in amino acid metabolism in prolactin secreting pituitary adenomas after bromocriptine treatment: A PET study (1987) J. Comput. Assist. Tomogr., 11, pp. 815-819
Biersack, H. J., Coenen, H. H., Stocklin, G., Imaging of brain tumors with L-3- (123I) iodo- -methyl tyrosine and SPECT (1989) J. Nucl. Med., 30, pp. 110-112
Biersack, H. J., Grunwald, F., Kropp, J., Single photon emission computed tomography imaging of brain tumours (1991) Semin. Nucl. Med., 21, pp. 2-10
Birnbaum, M. J., Haspel, H. C., Rosen, O. M., Transformation of rat fibroblasts by FSV rapidly increases glucose transport gene transcription (1987) Science, 233, pp. 1495-1498
Black, K. L., Hawkins, R. A., Kim, K. T., Use of thallium-201 SPECT to quantitate malignancy grade of gliomas (1989) J. Neurosurg., 71, pp. 342-346
Blacklock, J. B., Oldfield, E. H., Di Chiro, G., Effect of barbiturate coma on glucose utilization in normal brain versus gliomas: Positron emission tomography studies (1987) J. Neurosurg., 67, pp. 71-75
Bolster, J. M., Vaalburg, M., Paans, A. M. J., Carbon-11-labeled tyrosine to study tumor metabolism by positron emission tomography (PET) (1986) Eur. J. Nucl. Med, 12, pp. 321-324
Bottomley, P. A., The trouble with spectroscopy papers (1993) Radiology, 187, pp. 433-437
Bovee, W. M. M. J., Keevil, S. F., Leach, M. O., Podo, F., Quality assessment in in vivo NMR spectroscopy: A protocol for quality assessment (1995) Magn. Reson. Imaging, 13, pp. 123-129
Brooks, D. J., Beancy, R. P., Lammerstma, A. A., Quantitative measurement of blood-brain barrier permeability using rubidium-82 and positron emission tomography (1984) J. Cereb. Blood Flow Metab., 4, pp. 535-545
Buchpiguel, C. A., Alavi, J. B., Alavi, A., Kenyon, L. C., PET versus SPECT in distinguishing radiation necrosis from tumor recurrence in the brain (1991) J. Nucl. Med., 36, pp. 159-164
Burger, P. C., Shibata, T., Kleihues, P., The use of monoclonal antibody Ki-67 in the identification of proliferating cells: Applications to surgical neuropathology (1986) Am. J. Surg. Pathol., 10, pp. 611-617
Burger, P. C., Kleihues, P., Cytologic composition of the untreated glioblastoma with implications for evaluation of needle biopsy (1989) Cancer, 63, pp. 2014-2032
Burger, P. C., Scheithauer, B. W., Vogel, F. S., (1991) Surgical Pathology of the Nervous System and Its Coverings, 3rd Edn., , Churchill Livingstone, New York
Buxton, R. B., Wechsler, L. R., Alpert, N. M., Measurement of brain pH using 11CO and positron emission tomography (1984) J. Cereb. Blood Flow Metab., 4, pp. 8-16
Byrne, T. N., Imaging of gliomas (1994) Semin. Oncol., 21, pp. 162-171
Carvalho, P. A., Schwartz, R. B., Alexander E. III, Detection of recurrent gliomas with quantitative thallium-201/technetium-99m HMPAO single photon emission computerized tomography (1992) J. Neurosurg., 77, pp. 565-570
Cherry, S. R., Dahlbom, M., Huffman, E. J., Three-dimensional positron emission tomography using a conventional multi-slice tomograph without septa (1991) J. Comput. Assist. Tomogr., 15, pp. 655-668
Coleman, R. E., Hoffman, J. J., Hanson, M. W., Sostman, H. D., Schold, S. C., Clinical applications of PET for evaluation of brain tumors (1991) J. Nucl. Med., 32, pp. 616-622
Coons, S. W., Johnson, P. C., Regional heterogeneity in the DNA content of human gliomas (1993) Cancer, 72, pp. 3052-3060
Cox, P. H., Belfer, A. J., Van Der Pompe, W. B., Thallium-201 uptake in tumours: A possible complication on heart scintigraphy (1976) Br. J. Radiol., 49, pp. 767-768
Daemen, B. J. G., Zwertrbroek, R., Elsinga, P. H., PET studies of L- [I-11C] tyrosine, L- [methyl-11C] methionine and 18F-fluorodeoxyglucose in prolactinomas in relation to bromocriptine treatment (1991) Eur. J. Nucl. Med., 18, pp. 453-460
Davis, W. K., Boyko, O. B., Hoffman, J. M., [11F] 2-Fluoro-2-deoxyglucose-positron emission tomography correlation of gadolinium-enhanced MR imaging of central nervous system neoplasia (1993) AJNR, 14, pp. 515-523
Dean, B. L., Drayer, B. P., Bird, C. R., Gliomas: Classification with MR imaging (1990) Radiology, 174, pp. 411-415
De La Paz, R. L., Patronas, N. J., Brooks, R. A., Positron emission tomographic study of suppression of gray matter glucose utilization by brain tumors (1983) AJNR, 4, pp. 826-829
De Michele, D. J., Di Chiro, G., Grading meningiomas by positron emission tomography (1991) Meningiomos, pp. 243-251. , (Edited by Al Mefty O.). Raven Press, New York
Den Hollander, J. A., Luyten, P. R., Mariaen, J. H., Potentials of quantitative image-localized 31P nuclear magnetic resonance spectroscopy in the clinical evaluation of intracranial tumors (1989) Magn. Reson. Q., 5, pp. 152-168
Dierckx, R. A., Martin, J. J., Dobbleir, A., Crois, R., Neetens, I., De Deyn, P. P., Sensitivity and specificity of thallium-201 single photon emission tomography in the functional detection and differential diagnosis of brain tumors (1994) Eur. J. Nucl. Med., 21, pp. 621-633
Doyle, W. K., Budinger, T. F., Valk, P. E., Differentiation of cerebral radiation necrosis from tumor recurrence by [18F] FDG and 82Rb positron emission tomography (1987) J. Comput. Assist. Tomogr., 11, pp. 563-570
Drane, W. E., Abbott, F. D., Nicole, M. W., Technology for FDG-SPECT with a relatively inexpensive gamma camera: Work in progress (1994) Radiology, 191, pp. 461-465
El Gazzar, A. H., Fernandez-Ullo, M., Silberstein, E. B., Tl-201 as a tumor-localizing agent: Current status and future considerations (1993) Nucl. Med. Commun., 14, pp. 96-103
Ell, P. J., Jarritt, H., Costa, D. C., Functional imaging of the brain (1987) Semin. Nucl. Med., 17, pp. 214-229
Endicott, J. A., Ling, V., The biochemistry of P-glycoprotein-mediated drug resistance (1989) Annu. Rev. Biochem., 58, pp. 137-171
Ernst, R. R., Anderson, W. A., Application of fourier transform spectroscopy to magnetic resonance (1966) Rev. Sci. Instrum., 37, pp. 93-102
Evans, A. C., Beil, C., Marrett, S., Anatomical-functional correlation using an adjustable MRI-based region of interest atlas with positron emission tomography (1988) J. Cereb. Blood Flow Metab., 8, pp. 515-530
Fowler, J. S., Hoffman, E. J., Larson, S. M., Positron emission tomography in oncology (1988) JAMA, 259, pp. 2126-2131
Francavilla, T. L., Miletich, R. S., Di Chiro, G., Positron emission tomography in the detection of malignant degeneration of low-grade gliomas (1989) J. Neurosurg., 24, pp. 1-5
Fulham, M. J., Bizzi, A., Dietz, M. J., Mapping of brain tumor metabolites with proton MR spectroscopic imaging: Clinical relevance (1992) Radiology, 185, pp. 675-686
Fulham, M. J., Brunetti, A., Aloj, L., Decreased cerebral glucose metabolism in patients with brain tumors: An effect of corticosteroids (1995) J. Neurosurg., 83, pp. 657-664
Gadian, D. G., (1982) Nuclear Magnetic Resonance and Its Application to Living Systems, , Clarendon Press, Oxford
Gallen, C. C., Sobel, D. F., Levine, J. D., Neuromagnetic mapping of brain function (1993) Radiology, 187, pp. 863-869
Ginos, J. Z., Cooper, A. J. L., Dhawan, V., [N-13] Cisplatin PET to assess pharmacokinetics of intra-arterial versus intravenous chemotherapy for malignant brain tumors (1987) J. Nucl. Med., 28, pp. 1844-1852
Glantz, M. J., Hoffman, J. M., Coleman, R. E., Identification of early recurrence of primary central nervous system tumors by [18F] -fluorodeoxyglucose positron emission tomography (1991) Ann. Neurol., 29, pp. 347-355
Goldstein, L. J., Galsh, H., Fojo, A., Expression of a multidrug resistance gene in human cancers (1989) J. Natl. Cancer. Inst., 81, pp. 116-124
Graham, J. F., Cummins, C. J., Smith, B. K., Kornblith, P. L., Regulation of hexokinase in cultured gliomas (1985) Neurosurgery, 17, pp. 537-542
Haldemann, A. R., Roesler, H., Barth, A., Somatostatin receptor scintigraphy in central nervous system tumors: Role of blood-brain-barrier permeability (1995) J. Nucl. Med., 36, pp. 403-410
H m l inen, M., Hari, R., Ilmoniemi, R., Magnetoencephalography: Theory, instrumentation and applications to noninvasive studies of the working human brain (1993) Rev. Mod. Phys., 65, pp. 413-497
Hanson, M. W., Glantz, M. J., Hoffman, J. M., FDG-PET in the selection of brain lesions for biopsy (1991) J. Comput. Assist. Tomogr., 15, pp. 796-801
Hawkins, R. A., Phelps, M. E., Huang, S. -C., A kinetic evaluation of blood-brain barrier permeability in human brain tumors with [68Ga] EDTA and positron computed tomography (1984) J. Cereb. Blood Flow Metab., 4, pp. 507-515
Heiss, W. -D., Heindel, W., Herholz, K., Positron emission tomography of fluorine-18-deoxyglucose and image-guided phosphorus-31 magnetic resonance spectroscopy in brain tumors (1990) J. Nucl. Med., 31, pp. 302-310
Hoffman, J. M., Hanson, M. W., Friedman, H. S., FDG-PET in pediatric posterior fossa brain tumors (1992) J. Comput. Assist. Tomogr., 16, pp. 62-68
Hoffman, J. M., Waskin, H. A., Schifter, T., FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS (1993) J. Nucl. Med., 34, pp. 567-575
Holman, B. L., Carvalho, P. A., Zimmermann, R. E., Brain perfusion SPECT using an annular single crystal camera: Initial clinical experience (1990) J. Nucl. Med., 31, pp. 1456-1461
Holman, B. L., Hellman, R. S., Goldsmith, S. J., Computerassisted superimposition of magnetic resonance and high-resolution 99mTc HMPAO and 201Tl SPECT images (1991) J. Nucl. Med., 32, pp. 1478-1484
Howe, F. A., Canese, R., Podo, F., Quality assessment in vivo NMR spectroscopy: V. Multicentre evaluation of prototype test objects and protocols for performance assessment in small-bore MRS equipment of MRS test signals (1995) Magn. Reson. Imaging, 13, pp. 159-167
Hurtt, M. R., Moossy, J., Donovan Peluso, M., Locker, J., Amplification of epidermal growth factor receptor gene in gliomas: Histopathology and prognosis (1992) J. Neuropathol. Exp. Neuro., 51, pp. 84-90
Isen, H. W., Sato, M., Pawlik, 68Ga-EDTA positron emission tomography in the diagnosis of brain tumors (1984) Neuroradiolagy, 26, pp. 393-398
Jack, C. R., Thompson, R. M., Butts, R. K., Sensory motor cortex: Correlation of presurgical mapping with functional MR imaging and invasive cortical mapping (1994) Radiology, 190, pp. 85-92
James, C. D., Collins, V. P., Molecular genetic characterization of CNS tumor oncogenesis (1992) Adv. Cancer Res., 58, pp. 121-142
Jarden, J. O., Dhawan, V., Poltorak, A., PET measurement of blood-to-brain and blood-to-tumor transport of Rb-82: The effect of desamethasone and whole brain radiation therapy (1985) Ann. Neurol., 18, pp. 636-646
Kahn, D. A., Follett, K. A., Bushnell, D. L., Diagnosis of recurrent brain tumor: Value of 201Tl SPECT vs. 18F-fluorodeoxyglucose PET (1994) AJR, 163, pp. 1459-1463
Kaplan, W. D., Takvorian, T., Morris, J. H., Thallium-201 brain tumor imaging: A comparative study with pathologic correlation (1987) J. Nucl. Med., 28, pp. 47-52
Kasarov, L. B., Friedman, H., Enhanced Na+-K+ activated adenosine triphosphatase activity in transformed fibroblasts (1974) Cancer Res., 34, pp. 1862-1865
Keevil, S. F., Barbiroli, B., Collins, D. J., Quality assessment in in vivo NMR spectroscopy: IV. A multicentre trial of test objects and protocols for performance assessment in clinical NMR spectroscopy (1995) Magn. Reson. Imaging, 13, pp. 139-157
Kelly, J. D., Forster, A. M., Higley, B., Technetium-99m-tetrofosmin as a new radio-pharmaceutical for myocardial perfusion imaging (1993) J. Nucl. Med., 34, pp. 222-227
Kessler, R. M., Goble, J. C., Bird, J. H., Measurement of blood-brain barrier permeability with PET and Ga-68 EDTA (1984) J. Cereb. Blood Flow Metab., 4, pp. 323-328
Kim, K., Black, K. L., Marciano, D., Thallium-201 SPECT imaging of brain tumors: Methods and results (1990) J. Nucl. Med., 31, pp. 965-969
Kim, C. K., Alavi, J. B., Alavi, A., New grading system of cerebral gliomas using positron emission tomography and F-18 fluorodeoxyglucose (1991) J. Neurooncol., 10, pp. 85-91
Kim, D. K., Hoyt, J., Bacchi, C., Detection of proliferating cell nuclear antigen in gliomas and adjacent resection margins (1993) Neurosurgery, 33, pp. 619-625
Kooy, H. M., Van Herke, M., Barnes, P. D., Image fusion for stereotactic radiotherapy and radiosurgery treatment planning (1994) Int. J. Radiat. Oncol. Biol. Phys., 28, pp. 1229-1234
Lamberts, S. W. J., Krenning, E. P., Reubi, J. C., The role of somatostatin and its analogs in the diagnosis and treatment of tumors (1991) Endocr. Rev., 12, pp. 450-482
Lammertsma, A. A., Wise, R. J. S., Cox, T. C. S., Measurement of blood flow, oxygen utilization, oxygen extraction ratio and fractional blood-volume in human brain tumors and surrounding oedematous tissue (1985) Br. J. Radiol., 58, pp. 725-734
Langen, K. J., Roosen, N., Herzog, H., Investigations of brain tumors with 99mTc-HMPAO SPECT (1989) Nucl. Med. Commun., 10, pp. 325-334
Langen, K. J., Coenen, H. H., Roosen, N., SPECT studies of brain tumors with L-3- (123I) iodo- -methyl tyrosine: Comparison with PET 124I MT and first clinical results (1990) J. Nucl. Med., 31, pp. 281-286
Latchaw, R. E., Johnson, D. W., Kanal, E., Cranial and intracranial neoplasm (1991) MR and CT Imaging of the Head, Neck and Spine, 1, pp. 450-471. , Edited by Latchaw R. E., Mosby, St. Louis
Leach, M. O., Collins, D. J., Keevil, S., Quality assessment in in vivo NMR spectroscopy: III. Clinical test objects: Design construction and solutions (1995) Magn. Reson. Imaging, 13, pp. 131-137
Lear, J. L., Glycolysis link between PET and proton MR spectroscopic studies of the brain (1990) Radiology, 174, pp. 328-330
Lee, J. D., Kim, D. I., Lee, J. T., Chang, J. W., Park, C. Y., Indium-111-pentetreotide imaging in intra-axial brain tumors: Comparison with thallium-201 SPECT and MRI (1995) J. Nucl Med., 36, pp. 537-541
Leibel, S. A., Scott, C. B., Loeffler, J. S., Contemporary approaches for the treatment of malignant gliomas with radiation therapy (1994) Semin. Oncol., 21, pp. 198-219
Leichner, P. K., Morgan, H. T., Holdeman, K. P., SPECT imaging of fluorine-18 (1995) J. Nucl. Med., 36, pp. 1472-1475
Lenkinski, R. E., Holland, G. A., Allman, T., Integrated mr imaging and spectroscopy with chemical shift imaging of 31P at 1. 5 T: Initial clinical experience (1988) Radiology, 169, pp. 201-206
Lilja, A., Bergstr m, K., Hartvig, P., Dynamic studies of supratentorial gliomas with L-methyl-11C-methionine (1985) AJNR, 6, pp. 605-614
Luyten, P. R., Marien, A. J. H., Heindel, W., Metabolic imaging of patients with intracranial tumors: H1-MR spectroscopic imaging and PET (1990) Radiology, 176, pp. 791-799
Macfarlane, D. J., Cotton, L., Ackermann, R. J., Triple-head SPECT with 2-fluorine-18-fluoro-2-deoxy-D-glucose (FDG): Initial evaluation in oncology and comparison with FDG-PET (1995) Radiology, 194, pp. 425-429
Martin, W. H., Delbeke, D., Patton, J. A., FDG-SPECT: Correlation with FDG-PET (1995) J. Nucl. Med., 36, pp. 988-995
McComb, R. D., Bigner, D. D., The biology of malignant gliomas - A comprehensive study (1984) Clin. Neuropathol., 3, pp. 93-106
Meyer, G. J., Schober, O., Evaluation of brain rumors by PET (1991) Radiopharmaceuticals and Brain Pathology Studied with PET and SPECT, pp. 303-336. , (Edited by Diksic M. and Reba R. C.). CRC Press, Boca Raton, FL
Moats, R. A., Watson, L., Shonk, T., Added value of automated clinical proton spectroscopy of the brain (1995) J. Comput. Assist. Tomogr., 19, pp. 480-491
Mountz, J. M., Raymond, P. A., McKeever, P. E., Specific localization of thallium-201 in high-grade astrocytoma by microautoradiography (1989) Cancer Res., 49, pp. 4053-4056
Mountz, J. M., Stafford-Schuck, K., McKeever, P. E., Taver, J., Beierwaltes, W. H., Thallium-201 tumor/cardiac ratio estimation of residual astrocytoma (1989) J. Neurosurg., 68, pp. 705-709
Mountz, J. M., Deutsch, G., Kuzniecky, R., Rosenfeld, S. S., Brain SPECT: An update (1994) Nuclear Medicine Annual, pp. 1-54. , (Edited by Freeman L. M.). Raven Press, New York
Nadel, H. R., Thallium-201 for oncological imaging in children (1993) Semin. Nucl. Med., 23, pp. 243-254
Narayana, P. A., Johnston, D., Flamig, D. P., In vivo proton magnetic resonance spectroscopy studies of human brain (1991) Magn. Reson. Imaging, 9, pp. 303-308
Negendank, W. G., Studies of human tumors by MRS: A review (1992) NMR Biomed, 5, pp. 3903-3904
Negendank, W. G., Brown, T. R., Eveloch, J. L., Proceedings of a National Cancer Institute workshop: MR spectroscopy (1992) Radiology, 185, pp. 875-883
Noz, M. E., Maguire, G. Q., Multimodality image correlation and fusion (1995) Clinical SPECT Imaging, pp. 79-95. , (Edited by Kramer E. L. and Sanger J. J.). Raven Press, New York
Ogawa, S., Lee, T. M., Kay, A. R., Brain magnetic resonance imaging with contrast dependent on blood oxygenation (1990) Proc. Natl. Acad. Sci. USA, 87, pp. 9868-9872
O'Malley, J. P., Ziessman, H. A., Kumar, P. N., Diagnosis of intracranial lymphoma in patients with AIDS: Value of 201Tl single-photon emission computed tomography (1994) AJR, 163, pp. 217-221
Osborn, A. G., (1994) Diag
Functional characterization of brain tumors: An overview of the potential clinical value
Early detection and characterization are still challenging issues in the diagnostic approach to brain tumors. Among functional imaging techniques, a clinical role for positron emission tomography studies with [18F]-fluorodeoxyglucose and for single photon emission computed tomography studies with [201Tl]thallium-chloride has emerged. The clinical role of magnetic resonance spectroscopy is still being defined, whereas functional magnetic resonance imaging seems able to provide useful data for presurgical localization of critical cortical areas. Integration of morphostructural information provided by computed tomography and magnetic resonance imaging, with functional characterization and cyto-histologic evaluation of biologic markers, may assist in answering the open diagnostic questions concerning brain tumors.
Functional characterization of brain tumors: An overview of the potential clinical value